Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000124684 | SCV000168118 | benign | not specified | 2013-01-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000124684 | SCV000340952 | likely benign | not specified | 2016-04-21 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000603990 | SCV000745136 | likely benign | Pyruvate dehydrogenase E2 deficiency | 2017-06-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000603990 | SCV001121734 | benign | Pyruvate dehydrogenase E2 deficiency | 2024-12-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003390813 | SCV004133304 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | DLAT: BP4, BP7 |
Breakthrough Genomics, |
RCV003390813 | SCV005217606 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000603990 | SCV000732997 | likely benign | Pyruvate dehydrogenase E2 deficiency | no assertion criteria provided | clinical testing |